v3.26.3
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Treasury Stock
Accumulated Other Comprehensive Income/(Loss)
Total Common Shareholders' Equity
Noncontrolling Interests
Beginning Balance (in shares) at Dec. 31, 2024 [1]   64,446,892            
Beginning Balance at Dec. 31, 2024 $ 1,415,773 $ 779 [1] $ 981,140 [1] $ 561,746 $ (314,656) $ (1,179) $ 1,227,830 $ 187,943
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 36,768     64,915     64,915 (28,147)
Dividends declared (70,261)     (70,261)     (70,261)  
Amortization/issuance of restricted stock (2) [2] 68,664   68,664       68,664  
Issuance of treasury shares for options exercised (in shares) [1]   60,000            
Issuance of treasury shares for options exercised 1,485   16   1,469   1,485  
Issuance of treasury shares for restricted stock vestings (in shares) [1]   2,616,192            
Issuance of treasury shares for restricted stock vestings 0   (63,105)   63,105   0  
Repurchase of common stock from employees (in shares) [1]   (1,064,240)            
Repurchase of common stock from employees (80,629)       (80,629)   (80,629)  
Shares reserved/issued for director compensation (in shares) [1]   5,276            
Shares reserved/issued for director compensation 333   333       333  
Other comprehensive income/(loss) 1,136         1,136 1,136  
Fund capital contributions/(distributions), net 4,841           0 4,841
Ending Balance (in shares) at Mar. 31, 2025 [1]   66,064,120            
Ending Balance at Mar. 31, 2025 1,378,110 $ 779 [1] 987,048 [1] 556,400 (330,711) (43) 1,213,473 164,637
Beginning Balance (in shares) at Dec. 31, 2024 [1]   64,446,892            
Beginning Balance at Dec. 31, 2024 1,415,773 $ 779 [1] 981,140 [1] 561,746 (314,656) (1,179) 1,227,830 187,943
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income $ 151,001              
Repurchase of common stock through share repurchase program (in shares) [1] (267,032)              
Repurchase of common stock through share repurchase program $ (16,600)              
Repurchase of common stock from employees (in shares) [1] (1,180,448)              
Repurchase of common stock from employees $ (88,600)              
Ending Balance (in shares) at Sep. 30, 2025 [1]   66,920,888            
Ending Balance at Sep. 30, 2025 1,463,164 $ 779 [1] 971,462 [1] 629,830 (321,648) 2,415 1,282,838 180,326
Beginning Balance (in shares) at Mar. 31, 2025 [1]   66,064,120            
Beginning Balance at Mar. 31, 2025 1,378,110 $ 779 [1] 987,048 [1] 556,400 (330,711) (43) 1,213,473 164,637
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 31,755     42,182     42,182 (10,427)
Dividends declared (17,087)     (17,087)     (17,087)  
Amortization/issuance of restricted stock (2) [2] 7,927   7,927       7,927  
Repurchase of common stock through share repurchase program (in shares) [1]   (267,032)            
Repurchase of common stock through share repurchase program (16,573)       (16,573)   (16,573)  
Issuance of treasury shares for restricted stock vestings (in shares) [1]   1,053,192            
Issuance of treasury shares for restricted stock vestings 0   (28,726)   28,726   0  
Repurchase of common stock from employees (in shares) [1]   (71,400)            
Repurchase of common stock from employees (4,316)       (4,316)   (4,316)  
Shares reserved/issued for director compensation (in shares) [1]   11,424            
Shares reserved/issued for director compensation 725   725       725  
Other comprehensive income/(loss) 3,562         3,562 3,562  
Fund capital contributions/(distributions), net 15,311           0 15,311
Ending Balance (in shares) at Jun. 30, 2025 [1]   66,790,304            
Ending Balance at Jun. 30, 2025 1,399,414 $ 779 [1] 966,974 [1] 581,495 (322,874) 3,519 1,229,893 169,521
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 82,478     60,266     60,266 22,212
Dividends declared (11,931)     (11,931)     (11,931)  
Amortization/issuance of restricted stock (2) [2] 7,480   7,480       7,480  
Issuance of treasury shares for options exercised (in shares) [1]   72,000            
Issuance of treasury shares for options exercised 1,782   (247)   2,029   1,782  
Issuance of treasury shares for restricted stock vestings (in shares) [1]   101,896            
Issuance of treasury shares for restricted stock vestings 0   (2,875)   2,875   0  
Repurchase of common stock from employees (in shares) [1]   (44,808)            
Repurchase of common stock from employees (3,678)       (3,678)   (3,678)  
Shares reserved/issued for director compensation (in shares) [1]   1,496            
Shares reserved/issued for director compensation 130   130       130  
Other comprehensive income/(loss) (1,104)         (1,104) (1,104)  
Fund capital contributions/(distributions), net (11,407)           0 (11,407)
Ending Balance (in shares) at Sep. 30, 2025 [1]   66,920,888            
Ending Balance at Sep. 30, 2025 1,463,164 $ 779 [1] 971,462 [1] 629,830 (321,648) 2,415 1,282,838 180,326
Beginning Balance (in shares) at Dec. 31, 2025 [1]   67,483,432            
Beginning Balance at Dec. 31, 2025 1,582,793 $ 779 [1] 957,145 [1] 728,931 (318,581) 2,733 1,371,007 211,786
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 68,312     65,242     65,242 3,070
Dividends declared (113,633)     (113,633)     (113,633)  
Amortization/issuance of restricted stock (2) [2] 89,252   89,252       89,252  
Repurchase of common stock through share repurchase program (in shares)   (425,148)            
Repurchase of common stock through share repurchase program (33,046)       (33,046)   (33,046)  
Issuance of treasury shares for options exercised (in shares)   20,960            
Issuance of treasury shares for options exercised 519   (113)   632   519  
Issuance of treasury shares for restricted stock vestings (in shares)   1,232,616            
Issuance of treasury shares for restricted stock vestings 0   (41,719)   41,719   0  
Repurchase of common stock from employees (in shares)   (458,656)            
Repurchase of common stock from employees (36,843)       (36,843)   (36,843)  
Shares reserved/issued for director compensation (in shares)   4,357            
Shares reserved/issued for director compensation 313   313       313  
Other comprehensive income/(loss) (975)         (975) (975)  
Fund capital contributions/(distributions), net 1,167           0 1,167
Ending Balance (in shares) at Mar. 31, 2026   67,857,561            
Ending Balance at Mar. 31, 2026 1,557,859 $ 779 1,004,878 680,540 (346,119) 1,758 1,341,836 216,023
Beginning Balance (in shares) at Dec. 31, 2025 [1]   67,483,432            
Beginning Balance at Dec. 31, 2025 1,582,793 $ 779 [1] 957,145 [1] 728,931 (318,581) 2,733 1,371,007 211,786
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income $ 178,567              
Repurchase of common stock through share repurchase program (in shares) (1,316,011)              
Repurchase of common stock through share repurchase program $ (101,300)              
Repurchase of common stock from employees (in shares) (486,999)              
Repurchase of common stock from employees $ (39,000)              
Ending Balance (in shares) at Sep. 30, 2026   67,093,685            
Ending Balance at Sep. 30, 2026 1,562,042 $ 779 1,015,871 775,363 (411,390) 2,001 1,382,624 179,418
Beginning Balance (in shares) at Mar. 31, 2026   67,857,561            
Beginning Balance at Mar. 31, 2026 1,557,859 $ 779 1,004,878 680,540 (346,119) 1,758 1,341,836 216,023
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 70,097     67,845     67,845 2,252
Dividends declared (14,397)     (14,397)     (14,397)  
Amortization/issuance of restricted stock (2) [2] 7,632   7,632       7,632  
Repurchase of common stock through share repurchase program (in shares)   (385,508)            
Repurchase of common stock through share repurchase program (30,546)       (30,546)   (30,546)  
Issuance of treasury shares for restricted stock vestings (in shares)   71,864            
Issuance of treasury shares for restricted stock vestings 0   (2,506)   2,506   0  
Repurchase of common stock from employees (in shares)   (5,338)            
Repurchase of common stock from employees (421)       (421)   (421)  
Shares reserved/issued for director compensation (in shares)   10,870            
Shares reserved/issued for director compensation 862   862       862  
Other comprehensive income/(loss) (62)         (62) (62)  
Fund capital contributions/(distributions), net (23,600)           0 (23,600)
Ending Balance (in shares) at Jun. 30, 2026   67,549,449            
Ending Balance at Jun. 30, 2026 1,567,424 $ 779 1,010,866 733,988 (374,580) 1,696 1,372,749 194,675
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 40,158     55,415     55,415 (15,257)
Dividends declared (14,040)     (14,040)     (14,040)  
Amortization/issuance of restricted stock (2) [2] 7,492   7,492       7,492  
Repurchase of common stock through share repurchase program (in shares)   (505,355)            
Repurchase of common stock through share repurchase program (37,663)       (37,663)   (37,663)  
Issuance of treasury shares for restricted stock vestings (in shares)   70,966            
Issuance of treasury shares for restricted stock vestings 0   (2,599)   2,599   0  
Repurchase of common stock from employees (in shares)   (23,005)            
Repurchase of common stock from employees (1,746)       (1,746)   (1,746)  
Shares reserved/issued for director compensation (in shares)   1,630            
Shares reserved/issued for director compensation 112   112       112  
Other comprehensive income/(loss) 305         305 305  
Ending Balance (in shares) at Sep. 30, 2026   67,093,685            
Ending Balance at Sep. 30, 2026 $ 1,562,042 $ 779 $ 1,015,871 $ 775,363 $ (411,390) $ 2,001 $ 1,382,624 $ 179,418
[1] Common shares information and additional paid-in capital have been adjusted to reflect the four-for-one forward split of common stock, as discussed in Note 1.
[2] Includes amortization of restricted stock issued in conjunction with the Company's acquisitions.